Par-4 as a potential target for cancer therapy

Author： Irby Rosalyn B Kline Christina LB

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.1, 2013-01, pp. : 77-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PAR-4 as a possible new target for pancreatic cancer therapy

By Azmi Asfar S Philip Philip A Zafar Syed F Sarkar Fazlul H Mohammad Ramzi M

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 611-620

Informa Healthcare

Access to resources Recommend Favorite

uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1744-1760

Bentham Science Publishers

Access to resources Recommend Favorite

Par-4 for Molecular Therapy of Prostate Cancer

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

The centrosome as potential target for cancer therapy and prevention

By Korzeniewski Nina Hohenfellner Markus Duensing Stefan

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 43-52

Informa Healthcare

Access to resources Recommend Favorite

The Urokinase Receptor as a Potential Target in Cancer Therapy

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2359-2376

Bentham Science Publishers

Access to resources Recommend Favorite